Cutting edge: CTLA-4-B7 interaction suppresses Th17 cell differentiation

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1375-1378

  Ying, Haiyan ^a,b,d   Yang, Lifen ^c,d   Qiao, Guilin ^d   Li, Zhenping ^d   Zhang, Li ^d   Yin, Fei ^c   Xie, Dong ^a   Zhang, Jian ^d  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MYOSIN HEAVY CHAIN ALPHA; CD28 ANTIGEN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; GROWTH INHIBITOR; INTERLEUKIN 17; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; TH17 CELL; AMINO ACID SEQUENCE; ANIMAL; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DOWN REGULATION; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; HELPER CELL; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENETIC PREDISPOSITION TO DISEASE; GROWTH INHIBITORS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYOCARDITIS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77956399884     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903369     Document Type: Article

References (20)

1. Bettelli, E., M. Oukka, and V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
2. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485-517.
3. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19: 225-252.
4. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
5. Sonderegger, I., G. Iezzi, R. Maier, N. Schmitz, M. Kurrer, and M. Kopf. 2008. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205: 2281-2294.
6. + T cell-mediated experimental autoimmune myocarditis. J. Immunol. 180: 2686-2695.
7. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183: 2533-2540.
8. Carreno, B. M., F. Bennett, T. A. Chau, V. Ling, D. Luxenberg, J. Jussif, M. L. Baroja, and J. Madrenas. 2000. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J. Immunol. 165: 1352-1356.
9. Li, D., I. Gál, C. Vermes, M. L. Alegre, A. S. Chong, L. Chen, Q. Shao V. Adarichev, X. Xu, T. Koreny, et al. 2004. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173: 7135-7139. (Pubitemid 39628148)
10. + T cells. Immunity 7: 885-895.
11. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988.
12. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
13. Mandelbrot, D. A., A. J. McAdam, and A. H. Sharpe. 1999. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189: 435-440.
14. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101.
15. Egen, J. G., M. S. Kuhns, and J. P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3: 611-618.
16. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15: 297-322.
17. + Th cells that cause autoimmune arthritis. J. Exp. Med. 204: 41-47.
18. Rangachari, M., N. Mauermann, R. R. Marty, S. Dirnhofer, M. O. Kurrer, V. Komnenovic, J. M. Penninger, and U. Eriksson. 2006. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203: 2009-2019.
19. Ubaldi, V., L. Gatta, L. Pace, G. Doria, and C. Pioli. 2003. CTLA-4 engagement inhibits Th2 but not Th1 cell polarisation. Clin. Dev. Immunol. 10: 13-17.
20. McArthur, J. G., and D. H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J. Exp. Med. 178: 1645-1653.